Doherty Institute - Updated report - 13 October 2020 cover


Post-market validation of a further two serological assays for COVID-19

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date: 
13 October 2020
Last updated: 
19 October 2020
Publication type: 
Intended audience: 
Health sector

The Doherty Institute has evaluated 15 serology-based point of care tests.

The evaluation is part of a review of these tests by the Therapeutic Goods Administration (TGA).

These findings will inform the need for TGA to undertake any post-market action.

This could include changes to the instructions for use to include more information about the limitations of the tests.

Further information is on the TGA’s website, post-market evaluation of serology-based point of care tests.